Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia

QR Code

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by increased platelet destruction and decreased platelet production. The formation of antibodies to platelet and megakaryocyte glycoproteins plays a major role in the pathophysiology of ITP. All treatment strategies for ITP attempt...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. G. Zakharov, T. A. Mitina, A. V. Zakharova, O. P. Madzyara, I. N. Kontievskii, R. V. Vardanyan, E. V. Kataeva, Yu. B. Chernykh, L. L. Vysotskaya, L. V. Ivanitskiy, Yu. Yu. Chuksina, O. R. Zhuravlev, N. V. Gorgun, Z. M. Kharasova, E. V. Trifonova, K. A. Belousov, Z. R. Tekeeva
Format:	Article
Language:	Russian
Published:	ABV-press 2024-04-01
Series:	Онкогематология
Subjects:	immune thrombocytopenia thrombopoietin receptor agonist romiplostim eltrombopag avatrombopag
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/916
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01)

Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01)

Glucocorticosteroid-induced complications in patients with idiopathic thrombocytopenic purpura
by: S. G. Zakharov, et al.
Published: (2023-12-01)

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK
by: Nichola Cooper, et al.
Published: (2025-03-01)

Management of patients with immune thrombocytopenia in the Moscow region
by: S. G. Zakharov, et al.
Published: (2022-11-01)

Experience of 2<sup>nd</sup> line therapy with eltrombopag in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2023-09-01)

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
by: E. A. Pyadushkina, et al.
Published: (2016-02-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report
by: Kouki Hoshino, et al.
Published: (2019-04-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

SAFETY STUDY OF ROMIPLOSTIM BIOSIMILAR
by: A. N. Afanasyeva, et al.
Published: (2022-10-01)

Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune‐Mediated Thrombocytopenia
by: Josh M. Kennils, et al.
Published: (2025-07-01)

Investigation of the <i>ABCB1</i> Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic Analysis
by: Xin Liu, et al.
Published: (2025-06-01)

Development and Validation of Eltrombopag Determination in Human Plasma Blood by HPLC-MS Method
by: А. М. AL-Dhuraibi, et al.
Published: (2022-11-01)

Fisher-Evans syndrome. Casereport in physician’s practice
by: A. A. Yakushev, et al.
Published: (2020-01-01)

SOME THROMBOCYTE FACTORS DEVELOPMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C
by: N. Y. Pshenichnaya, et al.
Published: (2013-03-01)

Intrahospital switch of the P2Y12 inhibitors in patients with ST segment elevation myocardial infarction in ‘real-life’ clinical practice: the effect on the functional activity of thrombocytes and thrombocytopoiesis, prognostic value
by: L. I. Malinova, et al.
Published: (2019-09-01)

Clinical experience with romiplostim
by: G. B. Kuchma, et al.
Published: (2014-07-01)

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
by: V. A. Shuvaev, et al.
Published: (2014-07-01)

Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma
by: A. N. Afanaseva, et al.
Published: (2024-03-01)

Immune thrombocytopenia in the aspect of multiple primary neoplasms
by: R. V. Vardanyan, et al.
Published: (2023-09-01)

Corticosteroid-dependent chronic immune thrombocytopenic purpura in an 11-year-old child responsive to low-dose rituximab: a case report
by: Zainab Omar, et al.
Published: (2025-06-01)

Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation
by: S. V. Semochkin, et al.
Published: (2024-09-01)

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

Clinical and prognostic significance of T-regulatory cells and CD28 expression on T-lymphocytes in patients with immune thrombocytopenia
by: Yu. Yu. Chuksina, et al.
Published: (2024-12-01)

CHANGE IN THE ACTIVITY OF THROMBOPOIETIN, AS A REGULATOR OF THROMBOCYTOPOIESIS, WITH EXPERIMENTAL VIOLATION OF THE HEMOSTASIS SYSTEM
by: Alexander Aleksandrovich Vlasov, et al.
Published: (2022-10-01)

Experts Council Resolution on topical issues in the treatment of patients with idiopathic thrombocytopenic purpura (primary immune thrombocytopenia) and thrombopoietin receptor agonist (avatrombopag)
by: article Editorial
Published: (2022-04-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Lesions in the Fundus of the Eye in Patients with Acute Leukemia. Who Has, When and Why?
by: T. A. Mitina, et al.
Published: (2024-12-01)

The trend for transplant medicine development: induction of immune tolerance or regulation of immune response?
by: A. V. Kildyushevsky, et al.
Published: (2022-06-01)

Ensuring the Reliability of Conclusions in the Expert's Statement in the Course of a Forensic Construction Investigation
by: A. Yu. Butyrin, et al.
Published: (2017-09-01)

Relevance of An Expert Witness Report Submitted as Evidence in a Case
by: Z. V. Trifonova
Published: (2017-12-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

A clinical case of asymptomatic drug-induced thrombocytopenia
by: A. A. Zolotarev, et al.
Published: (2024-11-01)

Experimental Study of Diamond Burr Polishing Methods of Bowman’s Membrane
by: S. V. Trufanov, et al.
Published: (2018-07-01)

Diamond Burr Polishing of Bowman’s Layer in the Treatment of Subepithelial Fibrosis after Radial Keratotomy (Clinical Case)
by: S. V. Trufanov, et al.
Published: (2019-06-01)